Drug:
Reaction: GENERAL PHYSICAL HEALTH DETERIORATION
20250101 - 20251231
No. 401 - 500
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 401 | 25066151 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 402 | 25066550 |
US |
86 | 1 |
General physical health deterioration, |
||||
LENALIDOMIDE, |
||||
| 403 | 25067024 |
FR |
78 | 1 |
General physical health deterioration, |
||||
DOXORUBICIN, LENALIDOMIDE, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, RITUXIMAB, |
||||
| 404 | 25067414 |
DE |
84 | 2 |
Syncope, Bladder disorder, Exostosis, General physical health deterioration, |
||||
OXALIPLATIN, NIVOLUMAB, SPIRONOLACTONE, TORSEMIDE, FLUOROURACIL, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, PALONOSETRON, PALONOSETRON HYDROCHLORIDE, BISOPROLOL FUMARATE, CANDESARTAN, PANTOPRAZOLE, CALCIUM, ERGOCALCIFEROL, APIXABAN, |
||||
| 405 | 25067800 |
US |
2 | |
Bendopnoea, General physical health deterioration, Dyspnoea, Dyspnoea exertional, Peripheral swelling, Decreased activity, Mood altered, Joint swelling, |
||||
RIOCIGUAT, RIOCIGUAT, TREPROSTINIL, |
||||
| 406 | 25067893 |
CA |
2 | |
Helicobacter infection, Lower limb fracture, Lupus vulgaris, Sleep disorder, Eye injury, Headache, Blood cholesterol increased, Confusional state, Abdominal pain upper, Infusion related reaction, Therapeutic response decreased, Pain, Drug ineffective, Vomiting, Psoriatic arthropathy, Anxiety, Glossodynia, Lower respiratory tract infection, Irritable bowel syndrome, Condition aggravated, Product use issue, Rheumatoid arthritis, Leukopenia, Contraindicated product administered, Sleep disorder due to general medical condition, insomnia type, Pericarditis, Fatigue, General physical health deterioration, Dizziness, Folliculitis, Anti-cyclic citrullinated peptide antibody positive, Type 2 diabetes mellitus, Road traffic accident, Deep vein thrombosis postoperative, Stomatitis, Urticaria, Hand deformity, Injury, Discomfort, Alopecia, Ulcer haemorrhage, Drug hypersensitivity, Maternal exposure during pregnancy, Synovitis, Impaired healing, Hypertension, Prescribed overdose, Gastrointestinal disorder, Product use in unapproved indication, Diarrhoea, Rash pruritic, Pemphigus, Peripheral swelling, Nasopharyngitis, Muscle injury, Intentional product use issue, Pyrexia, Systemic lupus erythematosus, Weight increased, Sinusitis, Gait inability, Duodenal ulcer perforation, Asthma, Chest pain, Off label use, Swelling, Autoimmune disorder, Fibromyalgia, Drug intolerance, Liver disorder, |
||||
NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, HYDROXYCHLOROQUINE, TOFACITINIB, TOFACITINIB, OXYCODONE, LEFLUNOMIDE, ADALIMUMAB, ABATACEPT, ABATACEPT, TOCILIZUMAB, TOCILIZUMAB, ALENDRONATE SODIUM, PREDNISONE, PREDNISONE, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CALCIUM GLUCONATE, INFLIXIMAB, INFLIXIMAB, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, LEFLUNOMIDE, CELECOXIB, CELECOXIB, CALCIUM CARBONATE, CALCIUM CHLORIDE INJECTION, CALCIUM CHLORIDE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, CERTOLIZUMAB PEGOL, VITAMIN C, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, USTEKINUMAB, MAGNESIUM, CAFFEINE, LORAZEPAM, ERGOCALCIFEROL, LORAZEPAM, LANSOPRAZOLE, LISINOPRIL, |
||||
| 407 | 25068018 |
GB |
1 | |
Mental impairment, General physical health deterioration, |
||||
CLOZAPINE, |
||||
| 408 | 25069775 |
CO |
2 | |
Leukocytosis, Bronchitis, White blood cell count increased, Product intolerance, Influenza, Decreased immune responsiveness, Acne, Headache, General physical health deterioration, Psoriasis, Illness, Hidradenitis, Condition aggravated, Malaise, Breast discomfort, Vulvovaginal discomfort, Drug ineffective, Pruritus, Inflammation, Axillary pain, |
||||
SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, DOXYCYCLINE, DOXYCYCLINE HYCLATE, |
||||
| 409 | 25070107 |
IT |
57 | 1 |
General physical health deterioration, |
||||
| 410 | 25070164 |
CL |
80 | 1 |
General physical health deterioration, Malignant neoplasm progression, Weight decreased, Off label use, |
||||
CETUXIMAB, |
||||
| 411 | 25070208 |
US |
56 | 2 |
General physical health deterioration, Device infusion issue, Drug dose omission by device, Device alarm issue, |
||||
| 412 | 25070238 |
DE |
72 | 1 |
Retching, Retching, General physical health deterioration, Vomiting, Vomiting, |
||||
| 413 | 25070906 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 414 | 25070908 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 415 | 25070933 |
CA |
2 | |
Hypokalaemia, General physical health deterioration, Dysstasia, Gait disturbance, Grip strength decreased, C-reactive protein increased, Illness, Decreased appetite, Asthenia, Fatigue, Pain, Nausea, Drug ineffective, |
||||
HYDROXYCHLOROQUINE, METHOTREXATE, METHOTREXATE SODIUM, SULFASALAZINE, CELECOXIB, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, NAPROXEN, NAPROXEN SODIUM, HYDROXYCHLOROQUINE SULFATE, |
||||
| 416 | 25071057 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 417 | 25071177 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 418 | 25071179 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 419 | 25071199 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 DOTATATE, |
||||
| 420 | 25071329 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 421 | 25061335 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 422 | 25061490 |
CA |
2 | |
Colon cancer, Accident, Spinal fracture, General physical health deterioration, Wound, Back pain, Arthralgia, Neck pain, Pain, Injection site induration, Injection site warmth, |
||||
ADALIMUMAB-ADAZ, |
||||
| 423 | 25061501 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 424 | 25061530 |
US |
70 | 1 |
Urinary tract infection, Fall, Hallucination, Dyskinesia, Dizziness, General physical health deterioration, |
||||
PIMAVANSERIN TARTRATE, DROXIDOPA, APIXABAN, GLYCOPYRROLATE, RIVASTIGMINE, CARBIDOPA AND LEVODOPA, |
||||
| 425 | 25061550 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 426 | 25061715 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 427 | 25061807 |
US |
75 | 1 |
General physical health deterioration, |
||||
ABATACEPT, |
||||
| 428 | 25061932 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 429 | 25062044 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 430 | 25062098 |
CA |
52 | 2 |
Asthma, Breast cancer, Breath sounds abnormal, Bronchial obstruction, COVID-19, Chest pain, Cough, Dyspnoea, Fall, Gastrooesophageal reflux disease, General physical health deterioration, Nasal congestion, Nasopharyngitis, Obesity, Open fracture, Productive cough, Sputum discoloured, Upper respiratory tract infection, Weight decreased, Wheezing, Wrist fracture, Wrong technique in product usage process, Off label use, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, TIOTROPIUM BROMIDE, TIOTROPIUM BROMIDE, |
||||
| 431 | 25062287 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 432 | 25062630 |
JP |
9 | 2 |
Respiratory failure, Circulatory collapse, General physical health deterioration, Inadequate diet, |
||||
ICODEXTRIN, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE, |
||||
| 433 | 25062649 |
US |
2 | |
General physical health deterioration, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 434 | 25062887 |
CA |
40 | 2 |
Abdominal discomfort, Abdominal distension, Abdominal pain upper, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Asthenia, Back injury, Blepharospasm, Blister, Blood cholesterol increased, Breast cancer stage III, Bursitis, C-reactive protein abnormal, C-reactive protein increased, Coeliac disease, Condition aggravated, Confusional state, Depression, Diarrhoea, Dizziness, Drug hypersensitivity, Drug ineffective, Drug intolerance, Drug-induced liver injury, Dry mouth, Duodenal ulcer perforation, Dyspepsia, Dyspnoea, Epilepsy, Facet joint syndrome, Fall, Fatigue, Fibromyalgia, Finger deformity, Folliculitis, Gait inability, Gastrointestinal disorder, Gastrooesophageal reflux disease, General physical health deterioration, Glossodynia, Grip strength decreased, Hand deformity, Headache, Helicobacter infection, Hepatic enzyme increased, Hepatitis, Hypercholesterolaemia, Hypersensitivity, Hypertension, Hypoaesthesia, Ill-defined disorder, Impaired healing, Inflammation, Infusion related reaction, Injection site reaction, Injury, Insomnia, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Lip dry, Liver function test increased, Liver injury, Loss of personal independence in daily activities, Lower respiratory tract infection, Lung disorder, Malaise, Memory impairment, Migraine, Mobility decreased, Muscle injury, Muscle spasms, Muscular weakness, Musculoskeletal pain, Musculoskeletal stiffness, Nail disorder, Nasopharyngitis, Nausea, Neck pain, Night sweats, Obesity, Onychomadesis, Onychomycosis, Osteoarthritis, Pain, Pain in extremity, Paraesthesia, Pemphigus, Pericarditis, Peripheral swelling, Peripheral venous disease, Pneumonia, Product label confusion, Product quality issue, Psoriatic arthropathy, Rash, Rheumatic fever, Rheumatoid arthritis, Sleep disorder, Stomatitis, Swelling, Synovitis, Systemic lupus erythematosus, Taste disorder, Therapeutic product effect decreased, Treatment failure, Type 2 diabetes mellitus, Urticaria, Vomiting, Weight increased, Wheezing, Wound, Wound infection, Adverse event, Hospitalisation, |
||||
ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, VITAMIN C, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN AND CODEINE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ERENUMAB-AOOE, ERENUMAB-AOOE, ALENDRONATE SODIUM, ALENDRONATE SODIUM, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, ATOMOXETINE HYDROCHLORIDE, ATOMOXETINE HYDROCHLORIDE, ATOMOXETINE HYDROCHLORIDE, AZATHIOPRINE, BOTULINUM TOXIN TYPE A, BUPRENORPHINE, CALCIUM CARBONATE, ANTACID, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, SECUKINUMAB, SECUKINUMAB, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ERGOCALCIFEROL, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, GOLD, GOLIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, LAMOTRIGINE, LAMOTRIGINE, LAMOTRIGINE, MAGNESIUM CITRATE, MAJOR MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, CVS MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - LEMON, LEADER MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, HARRIS TEETER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHYLPREDNISOLONE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, MINOCYCLINE, MIRABEGRON, MIRABEGRON, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NICOTINAMIDE, MEPOLIZUMAB, APREMILAST, OXYCODONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, RAMIPRIL, RANITIDINE, INFLIXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, SULFASALAZINE, APREMILAST, CANDESARTAN CILEXETIL, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, USTEKINUMAB, USTEKINUMAB, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, TRAMADOL HYDROCHLORIDE, TOFACITINIB, TOFACITINIB, TOFACITINIB, |
||||
| 435 | 25063507 |
CA |
78 | 1 |
Death, Palliative care, Infusion site infection, Infusion site erythema, Infusion site induration, Cerebrovascular accident, Malaise, Gait disturbance, Fatigue, Infusion site bruising, Syncope, Immobile, Infusion site haemorrhage, Freezing phenomenon, Infusion site reaction, Infusion site injury, Mania, Unevaluable event, Mobility decreased, Orthostatic hypotension, Therapeutic product effect decreased, Dyskinesia, Gait inability, Catheter site discharge, General physical health deterioration, Infusion site reaction, |
||||
FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, BREXPIPRAZOLE, GABAPENTIN, MIRABEGRON, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, RIVASTIGMINE, FINASTERIDE, CLONAZEPAM, SILODOSIN, |
||||
| 436 | 25063516 |
CA |
72 | 1 |
Back pain, Drug resistance, General physical health deterioration, Psoas abscess, |
||||
LINEZOLID, AMOXICILLIN, CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, MEROPENEM, MOXIFLOXACIN HYDROCHLORIDE, MOXIFLOXACIN, TOBRAMYCIN, TOBRAMYCIN SULFATE, TOBRAMYCIN SOLUTION, |
||||
| 437 | 25063517 |
IT |
77 | 2 |
Epistaxis, Rectal haemorrhage, Haemoglobin decreased, Activated partial thromboplastin time ratio increased, Dehydration, Diarrhoea, General physical health deterioration, |
||||
SUNITINIB MALATE, WARFARIN SODIUM, WARFARIN, PREDNISONE, PANTOPRAZOLE, |
||||
| 438 | 25063527 |
CA |
81 | 1 |
Acute kidney injury, Dehydration, Diarrhoea, General physical health deterioration, Nausea, Vomiting, |
||||
SUNITINIB MALATE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, CALCIUM, APIXABAN, FUROSEMIDE, LEVOTHYROXINE, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, RANITIDINE, SIMVASTATIN, |
||||
| 439 | 25063881 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 440 | 25064435 |
US |
||
Laboratory test abnormal, General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 441 | 25064568 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 DOTATATE, |
||||
| 442 | 25065090 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 443 | 25065128 |
FR |
1 | |
Colorectal cancer metastatic, Thrombocytopenia, Drug intolerance, Lymphopenia, Anaemia, Gastrointestinal motility disorder, Sacral pain, Weight increased, Normocytic anaemia, C-reactive protein increased, Prealbumin increased, General physical health deterioration, Oedema peripheral, Gynaecomastia, Nipple pain, Neuralgia, Burn oesophageal, Blood creatinine increased, Blood thyroid stimulating hormone increased, Epistaxis, Dysphonia, Mucosal inflammation, Palmar-plantar erythrodysaesthesia syndrome, Pain in extremity, Weight decreased, |
||||
FRUQUINTINIB, FRUQUINTINIB, FRUQUINTINIB, |
||||
| 444 | 25065153 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 445 | 25065313 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 446 | 25065324 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 447 | 25065338 |
US |
||
General physical health deterioration, Ill-defined disorder, |
||||
LUTETIUM LU 177 DOTATATE, |
||||
| 448 | 25065793 |
CA |
43 | 2 |
Abdominal discomfort, Condition aggravated, Contraindicated product administered, Crohn^s disease, Decreased appetite, Deep vein thrombosis postoperative, Depression, Disability, Discomfort, Dizziness, Drug-induced liver injury, Alopecia, Drug ineffective, Drug intolerance, Duodenal ulcer perforation, Dyspepsia, Dyspnoea, Ear infection, Epilepsy, Exostosis, Fatigue, Fibromyalgia, Anti-cyclic citrullinated peptide antibody positive, Folliculitis, Foot deformity, Gait disturbance, Gait inability, General physical health deterioration, Glossodynia, Grip strength decreased, Hand deformity, Headache, Helicobacter infection, Arthropathy, Hepatic cirrhosis, Hepatic enzyme increased, Hypercholesterolaemia, Hypersensitivity, Hypertension, Hypoaesthesia, Ill-defined disorder, Impaired healing, Infection, Autoimmune disorder, Blepharospasm, Blister, Breast cancer stage III, Colitis ulcerative, Incorrect route of product administration, |
||||
ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, APREMILAST, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ERENUMAB-AOOE, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, HYDROXYCHLOROQUINE SULFATE, PREDNISONE, LEFLUNOMIDE, LEFLUNOMIDE, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CAFFEINE CITRATE, CALCIUM, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE, CETRIMIDE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CERTOLIZUMAB PEGOL, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, SECUKINUMAB, SECUKINUMAB, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DOXYCYCLINE, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCYCLINE HYCLATE, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, ETANERCEPT, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, GOLIMUMAB, ADALIMUMAB, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE BUTYRATE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, SARILUMAB, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LISINOPRIL, LISINOPRIL, LISINOPRIL, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, OXYCODONE, OXYCODONE, OXYCODONE, ABATACEPT, APREMILAST, PREGABALIN, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, RAMIPRIL, RAMIPRIL, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, SULFASALAZINE, SARILUMAB, GOLIMUMAB, GOLIMUMAB, USTEKINUMAB, USTEKINUMAB, USTEKINUMAB, USTEKINUMAB, USTEKINUMAB, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOFACITINIB, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, USTEKINUMAB, USTEKINUMAB, ERGOCALCIFEROL, PREDNISONE, PREDNISONE, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, |
||||
| 449 | 25068198 |
|||
General physical health deterioration, |
||||
TERIFLUNOMIDE, |
||||
| 450 | 25056381 |
US |
10 | 1 |
General physical health deterioration, Product availability issue, Drug ineffective, |
||||
DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE SULFATE AND AMPHETAMINE ASPARTATE, LISDEXAMFETAMINE DIMESYLATE, DEXTROAMPHETAMINE, METHYLPHENIDATE, METHYLPHENIDATE HYDROCHLORIDE, ATOMOXETINE HYDROCHLORIDE, METHYLPHENIDATE HYDROCHLORIDE, DEXMETHYLPHENIDATE HYDROCHLORIDE, CLONIDINE, DIPHENHYDRAMINE HYDROCHLORIDE, |
||||
| 451 | 25057061 |
US |
60 | 1 |
Weight decreased, Anal incontinence, Insomnia, Asthenia, Fatigue, Decreased appetite, Fibromyalgia, Blood pressure abnormal, Somnolence, General physical health deterioration, |
||||
EMPAGLIFLOZIN, ABEMACICLIB, ABEMACICLIB, ANASTROZOLE, ANASTROZOLE TABLETS, |
||||
| 452 | 25057183 |
RO |
||
General physical health deterioration, Respiratory failure, Hepatic cytolysis, Hyperuricaemia, Leukocytosis, Inflammatory marker increased, Early satiety, Hypertension, Fatigue, Asthenia, Decreased appetite, Blood creatinine increased, Nausea, |
||||
TEBENTAFUSP, |
||||
| 453 | 25057198 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 DOTATATE, |
||||
| 454 | 25057323 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 DOTATATE, |
||||
| 455 | 25057847 |
MX |
||
Toxic epidermal necrolysis, Septic shock, Liver injury, Gastrointestinal haemorrhage, Cardiac arrest, Multiple organ dysfunction syndrome, Renal injury, Hypokalaemia, Thrombocytopenia, Respiratory distress, Hypothermia, Conjunctivitis, Normochromic normocytic anaemia, Hypocalcaemia, Neutrophilia, Hyperglycaemia, Aspartate aminotransferase increased, Bacterial infection, Tachycardia, Hypotension, General physical health deterioration, Haemodynamic instability, Lymphopenia, Coagulopathy, Hypernatraemia, Hypochloraemia, Hyperlactacidaemia, Mucosal inflammation, Electrolyte imbalance, |
||||
LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, |
||||
| 456 | 25058612 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 457 | 25058663 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 458 | 25058666 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 DOTATATE, |
||||
| 459 | 25058668 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 DOTATATE, |
||||
| 460 | 25058731 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 461 | 25058750 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 462 | 25058751 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 463 | 25058756 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 464 | 25058781 |
DE |
87 | 1 |
Haematoma, Gait disturbance, Movement disorder, General physical health deterioration, |
||||
FOSCARBIDOPA/FOSLEVODOPA, FOSCARBIDOPA/FOSLEVODOPA, |
||||
| 465 | 25059124 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 DOTATATE, |
||||
| 466 | 25059125 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 DOTATATE, |
||||
| 467 | 25059126 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 468 | 25059127 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 DOTATATE, |
||||
| 469 | 25059359 |
FR |
||
Gastroduodenal ulcer, Disease progression, Hepatotoxicity, Device related thrombosis, Metastasis, Device related sepsis, Cholangitis, Metastases to liver, Complication of device insertion, Systemic toxicity, Catheter site inflammation, Device leakage, Device related infection, Arteritis, Catheter site haematoma, Off label use, Wound dehiscence, General physical health deterioration, |
||||
BEVACIZUMAB, PANITUMUMAB, |
||||
| 470 | 25059653 |
IT |
75 | 1 |
Guillain-Barre syndrome, Poor quality sleep, General physical health deterioration, Hallucination, |
||||
| 471 | 25059656 |
FR |
73 | 1 |
Death, General physical health deterioration, |
||||
TECLISTAMAB, TECLISTAMAB, |
||||
| 472 | 25059857 |
US |
1 | |
Renal cancer stage IV, General physical health deterioration, Product use in unapproved indication, |
||||
DUPILUMAB, ALBUTEROL SULFATE, ALPRAZOLAM, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, CITALOPRAM, CITALOPRAM HYDROBROMIDE, DUTASTERIDE, FAMOTIDINE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROXYZINE, LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, LEVOTHYROXINE, MEGESTROL ACETATE, METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, MORPHINE SULFATE, NALOXONE HCL, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, OXYCODONE HYDROCHLORIDE, OXYCODONE, PREDNISONE, PROCHLORPERAZINE, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SUMATRIPTAN, SUMATRIPTAN SUCCINATE, MUPIROCIN, MUPIROCIN CALCIUM, MIRTAZAPINE, PROPYLENE GLYCOL, NALOXONE HCL, LEVOTHYROXINE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, OXYCODONE HYDROCHLORIDE, OXYCODONE, |
||||
| 473 | 25059913 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 DOTATATE, |
||||
| 474 | 25059956 |
DE |
||
Haemorrhage, Thrombosis, General physical health deterioration, Hepatic function abnormal, Hepatic failure, |
||||
BEVACIZUMAB, ATEZOLIZUMAB, |
||||
| 475 | 25060392 |
CA |
65 | 2 |
Foot deformity, Pain in extremity, Spinal pain, Back pain, Increased appetite, Arthralgia, Osteoarthritis, Loss of personal independence in daily activities, General physical health deterioration, |
||||
| 476 | 25060445 |
AR |
63 | 2 |
General physical health deterioration, Skin irritation, Swelling face, Eye swelling, Skin erosion, Drug ineffective, Erythema, Pruritus, Rash, Facial pain, |
||||
PANITUMUMAB, |
||||
| 477 | 25060649 |
FR |
79 | 1 |
General physical health deterioration, Nausea, Diarrhoea, Pneumonia, Acute kidney injury, Rectal haemorrhage, Weight decreased, |
||||
ENCORAFENIB, ENCORAFENIB, BINIMETINIB, BINIMETINIB, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, RAMIPRIL, SPIRONOLACTONE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, SOLIFENACIN, POLYETHYLENE GLYCOL (3350), POLYETHYLENE GLYCOL 3350, POLYETHYLENE GLYCOL 400, BISOPROLOL FUMARATE, ENOXAPARIN SODIUM, |
||||
| 478 | 25060657 |
DE |
61 | 2 |
General physical health deterioration, Neutropenia, Leukopenia, |
||||
PALBOCICLIB, FULVESTRANT, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, ZOLEDRONIC ACID, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, |
||||
| 479 | 25060975 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 480 | 25060980 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 481 | 25061203 |
FR |
21 | 1 |
Ataxia, Behaviour disorder, Balance disorder, General physical health deterioration, |
||||
MONTELUKAST SODIUM, MONTELUKAST, |
||||
| 482 | 25055675 |
US |
2 | |
General physical health deterioration, Ill-defined disorder, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 483 | 25056069 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 484 | 25056123 |
FR |
78 | 1 |
General physical health deterioration, Off label use, |
||||
LENALIDOMIDE, RITUXIMAB, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, DOXORUBICIN, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, |
||||
| 485 | 25056217 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 DOTATATE, |
||||
| 486 | 25054843 |
FR |
||
Ascites, General physical health deterioration, |
||||
DURVALUMAB, TREMELIMUMAB, |
||||
| 487 | 25055399 |
JP |
59 | 2 |
Pneumonia, Pulmonary embolism, Pulmonary hypertension, General physical health deterioration, |
||||
TREPROSTINIL, |
||||
| 488 | 25055464 |
IN |
61 | 1 |
General physical health deterioration, Jaundice, Blood bilirubin increased, White blood cell count decreased, |
||||
IRINOTECAN HYDROCHLORIDE, IRINOTECAN HYDROCHLORIDE, |
||||
| 489 | 25055616 |
US |
64 | 1 |
General physical health deterioration, Treatment noncompliance, |
||||
SOMATROPIN, |
||||
| 490 | 25048215 |
CA |
||
General physical health deterioration, Pneumonia, |
||||
RITUXIMAB, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, TICAGRELOR, CALCIUM, CELECOXIB, CYANOCOBALAMIN, DICLOFENAC, DICLOFENAC SODIUM, DUTASTERIDE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, MORPHINE SULFATE, MOMETASONE FUROATE, NITROGLYCERIN, PANTOPRAZOLE, PREDNISONE, RISEDRONATE SODIUM, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, ERGOCALCIFEROL, |
||||
| 491 | 25048502 |
US |
1 | |
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 492 | 25048522 |
US |
||
General physical health deterioration, Laboratory test abnormal, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 493 | 25048523 |
83 | 1 | |
Blood pressure fluctuation, General physical health deterioration, Tremor, Lethargy, |
||||
| 494 | 25048543 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
| 495 | 25048595 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 DOTATATE, |
||||
| 496 | 25048742 |
DE |
1 | |
General physical health deterioration, Asthenia, On and off phenomenon, Dementia, Hallucination, Enteral nutrition, Dysphagia, |
||||
| 497 | 25048837 |
FR |
80 | 1 |
Loss of consciousness, Hypotension, Epilepsy, On and off phenomenon, General physical health deterioration, |
||||
FOSCARBIDOPA/FOSLEVODOPA, |
||||
| 498 | 25049026 |
CA |
||
Abdominal discomfort, Adjustment disorder with depressed mood, Alopecia, Amnesia, Anti-cyclic citrullinated peptide antibody, Anti-cyclic citrullinated peptide antibody positive, Anxiety, Arthritis, Arthropathy, Autoimmune disorder, Blister, Blood cholesterol increased, Bone erosion, Breast cancer stage I, C-reactive protein increased, Chest pain, Condition aggravated, Confusional state, Contusion, Crohn^s disease, Decreased appetite, Deep vein thrombosis postoperative, Delirium, Depression, Diarrhoea, Disability, Discomfort, Dislocation of vertebra, Dizziness, Drug-induced liver injury, Duodenal ulcer perforation, Dyspepsia, Exostosis, Fatigue, Fibromyalgia, Foot deformity, Gait disturbance, Gait inability, General physical health deterioration, Glossodynia, Grip strength decreased, Hypoaesthesia, Hand deformity, Headache, Hepatic cirrhosis, Hepatic enzyme increased, Hip arthroplasty, Hypercholesterolaemia, Hypersensitivity, Hypertension, Infusion related reaction, Injury, Irritable bowel syndrome, Joint dislocation, Joint range of motion decreased, Joint stiffness, Joint swelling, Liver function test increased, Liver injury, Loss of personal independence in daily activities, Lower limb fracture, Lupus-like syndrome, Oedema peripheral, Memory impairment, Mobility decreased, Muscle injury, Muscular weakness, Musculoskeletal stiffness, Nausea, Impaired healing, Osteoarthritis, Pain, Pain in extremity, Pemphigus, Pericarditis, Peripheral swelling, Pruritus, Psoriasis, Psoriatic arthropathy, Pulmonary fibrosis, Pyrexia, Rash, Osteoporosis, Red blood cell sedimentation rate increased, Oedema, Knee arthroplasty, Rheumatic fever, Rheumatoid arthritis, Bronchitis, Infection, Helicobacter infection, Laryngitis, Folliculitis, Lupus vulgaris, Ear infection, Nasopharyngitis, Pneumonia, Retinitis, Prescribed overdose, Prescribed underdose, |
||||
ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ALENDRONATE SODIUM, ALENDRONATE SODIUM, APREMILAST, AZATHIOPRINE, CALCIUM, CALCIUM CARBONATE, ANTACID, CELECOXIB, CERTOLIZUMAB PEGOL, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CERTOLIZUMAB PEGOL, INFLIXIMAB, HYDROCORTISONE, CORTISONE ACETATE, DESOXIMETASONE, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DILTIAZEM HYDROCHLORIDE, DILTIAZEM HYDROCHLORIDE EXTENDED-RELEASE TABLETS, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, ETANERCEPT, VEDOLIZUMAB, FOLIC ACID, GOLIMUMAB, ADALIMUMAB, HYDROCORTISONE SODIUM SUCCINATE, CLONIDINE HYDROCHLORIDE, CLONIDINE, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, MESALAMINE, METHOTREXATE, METHOTREXATE SODIUM, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, QUETIAPINE FUMARATE, QUETIAPINE, |
||||
| 499 | 25049093 |
IT |
85 | 1 |
Encephalopathy, Hallucination, Confusional state, Psychomotor hyperactivity, General physical health deterioration, |
||||
VALACYCLOVIR HYDROCHLORIDE, VALACYCLOVIR, |
||||
| 500 | 25049098 |
US |
||
General physical health deterioration, |
||||
LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-04-28